Answers are grounded in this paper and cite their sources.
Finds kisspeptin signaling inhibits tumor growth and metastasis in NIH3T3 cells, suggesting a potential target for therapy.
Background/Aim: Kisspeptin signaling is recognized as a metastasis-suppressive pathway, but its role in oncogenic HRAS-driven tumor progression remains incompletely understood. This study investigated whether kisspeptin signaling suppresses HRASG12V-induced tumorigenic and metastatic phenotypes in NIH3T3 cells and examined the involvement of SP1-dependent transcription of N-cadherin. Materials and Methods: NIH3T3 cells expressing HRASG12V, KISS1, and KISS1R were analyzed for proliferation, migration, invasion, luciferase reporter activity, anchorage-independent growth, and in vivo tumor growth and pulmonary metastasis. N-cadherin expression was examined by RT-PCR and immunoblotting. N-cadherin promoter regulation was analyzed using luciferase reporter and chromatin immunoprecipitation assays. Results: Kisspeptin signaling reduced NIH3T3 cell proliferation, migration, and invasion and activated SRF reporter activity through the KISS1R–Gaq/11–p63RhoGEF–RhoA pathway. In HRASG12V-expressing NIH3T3 cells, KISS1 reduced N-cadherin expression and suppressed anchorage-independent colony formation. HRASG12V increased N-cadherin promoter activity, whereas KISS1 reduced both basal and HRASG12V-induced promoter activation. Deletion of the SP1-responsive region abolished these effects, and chromatin immunoprecipitation showed reduced SP1 binding to the N-cadherin promoter. In vivo, KISS1 suppressed HRASG12V-induced tumor growth and pulmonary metastasis, and N-cadherin expression reversed these effects. Conclusion: Kisspeptin signaling suppresses HRASG12V-induced tumor growth and metastasis in NIH3T3 cells by inhibiting SP1-dependent transcription of N-cadherin.
No takes yet. Share an insight, caveat, or question.
Hwang et al. (2026) studied this question.
Synapse has enriched 10 related papers. Consider them for comparative context: